Classification of Chemotherapeutic Agents According to their Mechanisms of Action

Clarysse, Albert; Kenis, Yvon; Mathé, G

doi:10.1007/978-3-642-81010-7_3

Cancer Chemotherapy 1976

DOI: 10.1007/978-3-642-81010-7_3

|View full text |Cite

Classification of Chemotherapeutic Agents According to their Mechanisms of Action

Albert Clarysse¹,

Yvon Kenis²,

G Mathé³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1982

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 93 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Alterations in Thyroid Hormone Metabolism During Chemotherapy in Patients With Testicular Carcinoma

Willemse¹,

Sleijfer²,

Sluiter³

et al. 1982

Clinical Endocrinology

View full text Add to dashboard Cite

In a prospective study, the effects of chemotherapy on thyroid function in patients with non-seminoma testicular carcinoma were evaluated. Thirty-one patients were studied; in sixteen immunoassayable HCG was present, but altered thyroid function could not be established. In fifteen patients an exaggerated TSH response to TRH was observed. In these patients, although T3 and T4N values were normal, basal TSH levels were higher compared to patients with a normal TSH response, probably due to preceding lymphangiography. During chemotherapy, T4N, T3 and rT3 levels rose significantly, but basal TSH levels and the TSH response to TRH decreased. In contrast, the prolactin responses to TRH increased. The observed changes in thyroid function during chemotherapy appear to result from delayed thyroid hormone clearance, probably caused by an effect of chemotherapy on deiodinating enzyme activity. This would result, in an increase in T4N and rT3 levels and a fall in TSH levels and in the TSH response to TRH. Furthermore, after therapy the raised T4N and lowered TSH levels remained, whilst the FT3 level did not change either during or after therapy, suggesting an unaltered hypothalamic/pituitary axis.

show abstract

Alterations in Thyroid Hormone Metabolism During Chemotherapy in Patients With Testicular Carcinoma

Willemse¹,

Sleijfer²,

Sluiter³

et al. 1982

Clinical Endocrinology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Classification of Chemotherapeutic Agents According to their Mechanisms of Action

Cited by 1 publication

References 93 publications

Alterations in Thyroid Hormone Metabolism During Chemotherapy in Patients With Testicular Carcinoma

Alterations in Thyroid Hormone Metabolism During Chemotherapy in Patients With Testicular Carcinoma

Contact Info

Product

Resources

About